2023-10-04 10:14:01
NOVARTIS (CQAW039A2317) – Latin Clinical Trial Center

NOVARTIS (CQAW039A2317)

A 12-week, multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma

Join the discussion 6 Comments

Leave a Reply